V. Moreno

Analysis of the immune-related endpoints of the mismatch repair–deficient non-endometrial solid cancers cohort from the GARNET study

Background Dostarlimab is a humanized monoclonal antibody that binds the programmed cell death protein 1 (PD-1) receptor and blocks interaction with its ligands PD-L1 and PD-L2. The GARNE...

D. Berton ;

T. Andre ;

G. Curigliano ;

H. Arkenau ;

J. Trigo ;

S. Ellard ;

V. Moreno ;

C. Abdeddaim ;

A. Anton ;

S. Kumar ;

W. Guo ;

E. Im ;

Naureen Starling , MBBS, MD;

07/01/2021

O-005: Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT ‘basket’ trial

Access the abstract

Alshad S. Lalani ;

Richard Bryce ;

Funda Meric Bernstam ;

James J. Harding ;

David B. Solit ;

Sherene Loi , MBBS, PhD;

James M. Cleary ;

David M. Hyman ;

Geoffrey I. Shapiro ;

Sarina Piha-Paul ;

Irene Braña ;

David Quinn ;

Mitesh Borad ;

Iben Spanggaard ;

Salomon M. Stemmer ;

Melanie E. Dujka ;

Richard E. Cutler Jr.;

Feng Xu ;

V. Moreno ;

Lisa D. Eli ;

Sonia Macia ;

07/31/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

V. Moreno

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products